Intermittent fasting resulted in similar weight loss as traditional calorie restriction, according to a new review. One form of intermittent fasting, known as whole-day fasting, did yield slightly ...

A new study reports that people taking GLP-1 drugs in daily life don’t lose as much weight as those in clinical trials who take the same medications. One possible reason for the weight loss ...

Amanda Bynes is announcing she’s starting a weight loss journey and turning to Ozempic for help.

Following a low-fat vegan diet may lower dietary acid load, which may help with weight loss, a new study has concluded.

A restrictive diet can backfire, making it hard to lose weight long-term. New research shows why it's so beneficial to indulge in your cravings a little.

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly one-quarter of their body weight in early trials.

Lizzo shared new details about her recent weight loss journey and got real about weight-loss drugs in a new appearance on the “Just Trish” podcast, hosted by internet personality Trisha Paytas ...

Discover how actor Ram Kapoor lost 55 kilos naturally in 18 months by following three simple diet rules. Learn about his two-meals-a-day approach, no snacking habits, and avoiding late meals to ...

Whether it's Lizzo trimming her BMI or John Goodman showing off his 200-pound weight loss, these stars' weight loss journeys have produced undeniable body transformations.

Novo Nordisk on Friday said full results from early-stage trials show that its experimental drug, amycretin, helped overweight and obese adults lose up to 24% of their weight as the Danish company ...

When it comes to weight loss, knowing which type of exercise is the best can be a challenge. So, we asked experts to weigh in on whether HIIT, strength training, cardio, or Pilates is best for ...

Medicine Ozempic without the side effects? New drug touted as weight loss game changer By Diana Bruk Published June 26, 2025, 5:36 p.m. ET ...